|
Αμφιθέατρο
|
|
09:00 - 09:15
|
Chairpersons Welcome and Opening Remarks
J. Vassiliadou & A. Chaniotis, members of the EL.E.F.I BoD
|
|
09:15 - 10:15
|
The MSL Role Fundamentals
Moderator: A. Karantzas, Medical Mgr, GSK
- Skills and Knowledge required to deliver Excellence K. Giannouli, MSL, Astra Zeneca
- Building and Maintaining long-term relationships with external stakeholders Ioanna Nikoloutsou, Field-facing medic, GSK
|
|
10:15 - 11:15
|
MSL good practices: Sharing Ideas & Initiatives
- Build, manage and lead MSL Teams G. Mitas, Medical Manager, AbbVie
- Named Patient Programs: the role of the MSL A Desiniotis, EMEA Med Advisor, Janssen-Cilag
- Clinical Trials: the role of the MSL, V. Tsironi, MSL, Janssen-Cilag
- How to effectively cope with challenges regarding internal & external perceptions of the MSL role? S. Tsalavos, MSL, Roche
|
|
10:45 - 11:30
|
Refreshments Break
|
|
11:30 - 12:30
|
Measuring MSL Impact: the KPIs Discussion
Moderator: V. Baroutsou, WEC Chief Scientific Officer, Novartis
- Claudia Bremer, Global Field Medical Excellence Director, NVS,
- Peter Hans Killian, MSL Manager, GSK
Ομιλητής
D. Tsopka
Regional MSL Excellence Lead, Astra Zeneca
|
|
12:30 - 13:30
|
Networking Lunch
|
|
13:30 - 14:30
|
The MSL Career Path: Hearing from the Leaders
Moderator: V. Baroutsou, WEC Chief Scientific Officer, Novartis
- Claudia Bremer, Global Field Medical Excellence Director, NVS,
- Peter Hans Killian, MSL Manager, GSK
Συντονιστής
V. Baroutsou
WEC Chief Scientific Officer, Novartis
|
|
14:30 - 15:30
|
The evolution of the MSL role
Moderator: Tina Antachopoulou, Medical Director, AbbVie
Discussion Panel:
- N. Theofanidis, MSL, NVS,
- A. Papadakis, MSL, Actelion,
- A. Karantzas, Medical Manager, GSK
- A. Chaniotis, Knowledge Dissemination Mgr, Janssen-Cilag
|
|
15:30 - 16:00
|
Refreshments Break
|
|
16:00 - 16:30
|
Chairpersons Closing Remarks
J. Vassiliadou & A. Chaniotis, members of the EL.E.F.I BoD
|
